HEALTH● LOW1h ago · Oct 2, 2026, 6:21 PM
Experimental Combo Boosts Weight Loss in T2D
Human Progress · global
“A next-generation weight-loss drug from Eli Lilly red down pointing triangle, when combined with Zepbound, helped people lose substantially more weight than Zepbound alone, according to a new study. The experimental injection, eloralintide, which mimics a hormone called amylin that helps signal fullness after eating, was studied in combination with a Zepbound shot in patients […] The post Experimental Combo Boosts Weight Loss in T2D appeared first on Human Progress.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH1h agoMamapalooza, a gathering for breast health and early detection of diseasesClarínHEALTH2h agoMeet Bolu Ogunyemi, first black physician to lead Canadian Medical AssociationVanguard NigeriaHEALTH3h agoDNA Tagging Silences Hepatitis B Virus in Lab and Animal TestsHuman ProgressHEALTH3h agoDR Congo Ebola outbreak killed more than 4,000: official figuresEuroNews [en]